Joseph G. Rajendran

机构：United States Food and Drug Administration

发表论文 104 篇 · 总被引 5368 次 · h-index 34

代表论文

• Hypoxia imaging with [F-18] FMISO-PET in head and neck cancer: Potential for guiding intensity modulated radiation therapy in overcoming hypoxia-induced treatment resistance (2011 · Radiotherapy and Oncology · 被引 192)
• F-18 Fluoromisonidazole for Imaging Tumor Hypoxia: Imaging the Microenvironment for Personalized Cancer Therapy (2015 · Seminars in Nuclear Medicine · 被引 124)
• Radiolabeled Anti-CD45 Antibody with Reduced-Intensity Conditioning and Allogeneic Transplantation for Younger Patients with Advanced Acute Myeloid Leukemia or Myelodysplastic Syndrome (2014 · Transplantation and Cellular Therapy · 被引 71)
• 90Y-Ibritumomab tiuxetan, fludarabine, and TBI-based nonmyeloablative allogeneic transplantation conditioning for patients with persistent high-risk B-cell lymphoma (2011 · Blood · 被引 67)
• PR-104 a bioreductive pre-prodrug combined with gemcitabine or docetaxel in a phase Ib study of patients with advanced solid tumours (2012 · BMC Cancer · 被引 65)
• 18F-Fluoromisonidazole Quantification of Hypoxia in Human Cancer Patients Using Image-Derived Blood Surrogate Tissue Reference Regions (2015 · Journal of Nuclear Medicine · 被引 37)